Microbot Medical Inc. filed a Form 8-K on October 27, 2026, disclosing that California-based multisite outpatient interventional radiology practice ELMNT IR has signed an order to purchase up to a 12-month supply of the company's LIBERTY Endovascular Robotic System devices.

Key Highlights

  • New customer order: ELMNT IR, a multisite outpatient interventional radiology practice in California, signed an order to purchase up to a 12-month supply of the LIBERTY Endovascular Robotic System devices, according to the filing.
  • First Office-Based Laboratory customer globally: The filing states ELMNT IR became the first Office-Based Laboratory customer in the world to utilize the LIBERTY Endovascular Robotic System.
  • First West Coast customer: According to the filing, ELMNT IR is also described as the company's first customer on the West Coast.
  • Disclosure method: The information was disseminated via a press release furnished as Exhibit 99.1 and is being treated as Regulation FD disclosure under Item 7.01.
  • Filing signed by: Harel Gadot, Chief Executive Officer, President and Chairman of Microbot Medical Inc.

ELMNT IR Signs Supply Order for Microbot Medical's LIBERTY System

According to the Form 8-K filed with the SEC on October 27, 2026, Microbot Medical Inc. (NASDAQ:MBOT) announced through a press release that ELMNT IR has signed an order covering up to a 12-month supply of the company's LIBERTY Endovascular Robotic System devices. ELMNT IR is described in the filing as a multisite outpatient interventional radiology practice located in California.

The filing characterizes this customer relationship as carrying two distinct firsts for the company. ELMNT IR is described as both the first Office-Based Laboratory customer in the world to utilize the LIBERTY Endovascular Robotic System and the company's first customer on the West Coast. The filing does not specify the dollar value of the order or the number of devices included in the purchase commitment.

The disclosure was made under Item 7.01 (Regulation FD Disclosure), with the underlying press release furnished as Exhibit 99.1. The filing notes that the information "shall not be deemed to be 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934" and that "the Company is making no admission as to the materiality of any information in this Item 7.01 or Exhibit 99.1."

What Was Disclosed

Microbot Medical filed an 8-K on October 27, 2026, disclosing that ELMNT IR, a California-based interventional radiology practice, signed an order for up to a 12-month supply of LIBERTY Endovascular Robotic System devices, representing two claimed firsts for the company.